EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese

Bing Wei, Jiadong Zhao, Jun Li, Junnan Feng, Manman Sun, Zhizhong Wang, Chao Shi, Ke Yang, Yue Qin, Jing Zhang, Jie Ma iD, Hui Dong iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Bing Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Henan Key Laboratory of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer…. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Innovation Plan of Shanghai General Hospital, Shanghai General Hospital Start-up Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Backgroud Multiple studies have identified pathogenic germline variants in cancer susceptibility genes (CSGs) in Chinese lung cancer patients; however, accurate assessment of these variants' contributions to cancer predisposition is always hampered by the absence of data on the prevalence of these variants in the general population. It is necessary to conduct a large‐scale case–control study to identify CSGs that significantly increase the risk of lung cancer. Materials and methods We performed targeted sequencing of a CSGs panel in 1117 lung cancer patients and 16,327 controls from the general Chinese population.

Results

In comparison to controls, lung cancer patients had a considerably higher prevalence of pathogenic and likely pathogenic (P/LP) variations. Among lung cancer patients, 72% of P/LP variants carriers did not have a family cancer history, who would be ignored if germline testing was only provided for patients meeting family history‐based criteria. Furthermore, compared to individuals with late‐onset lung cancer, patients with early‐onset lung cancer had a considerably higher prevalence of P/LP variations. With odds ratios (ORs) ranging from 4‐fold ( BRCA1 : OR, 4.193; 95%CI, 1.382–10.768) to 29‐fold ( TP53 : OR, 29.281; 95%CI, 1.523–1705.506), P/LP variants in the BRCA1 and TP53 genes were discovered to be strongly related to increased lung cancer risk. Additionally, with ORs ranging from 7.322‐fold to infinity, we discovered 23 variations previously categorized as non‐P/LP variants were highly enriched in lung cancer patients.

Conclusion

Our findings indicated that P/LP variants in BRCA1 and TP53 conferred increased risk of lung cancer in Chinese.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseLung NeoplasmsHumansCase-Control StudiesBRCA2 ProteinBRCA1 ProteinGerm-Line MutationChinaGerm CellsTumor Suppressor Protein p53

Stichwörter der Autor:innen

BRCA1TP53Chinesegermline variantslung cancer

Substanzen

BRCA2 ProteinBRCA1 ProteinTP53 protein, humanTumor Suppressor Protein p53BRCA1 protein, human

Autor:innen und Institutionen

  • Department of Molecular Pathology, Henan Key Laboratory of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China.
  • Nanjing Shenyou Institute of Genome Research, Nanjing, Jiangsu, China.
  • Department of Gastroenterology, Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Jie Ma, Hui Dong

Förderung

  • Clinical Research Innovation Plan of Shanghai General Hospital
  • Shanghai General Hospital Start-up Fund

Zitieren

APA

Wei, B., Zhao, J., Li, J., Feng, J., Sun, M., Wang, Z., Shi, C., Yang, K., Qin, Y., Zhang, J., Ma, J., & Dong, H. (2023). Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese. Cancer Medicine. https://doi.org/10.1002/cam4.6692

Vancouver

Wei B, Zhao J, Li J, Feng J, Sun M, Wang Z, et al. Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese. Cancer Medicine. 2023. doi:10.1002/cam4.6692

BibTeX
@article{Wei2023,
  author = {Wei, Bing and Zhao, Jiadong and Li, Jun and Feng, Junnan and Sun, Manman and Wang, Zhizhong and Shi, Chao and Yang, Ke and Qin, Yue and Zhang, Jing and Ma, Jie and Dong, Hui},
  title = {Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6692}
}
Kostenlos starten →